- Home
- MNOV vs ATLX Comparison
MNOV vs ATLX Comparison
Compare MNOV & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- ATLX
- Stock Information
- Founded
- MNOV 2000
- ATLX 2011
- Country
- MNOV United States
- ATLX Brazil
- Employees
- MNOV N/A
- ATLX N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- MNOV Health Care
- ATLX Industrials
- Exchange
- MNOV Nasdaq
- ATLX Nasdaq
- Market Cap
- MNOV 87.3M
- ATLX 101.9M
- IPO Year
- MNOV 2005
- ATLX N/A
- Fundamental
- Price
- MNOV $1.83
- ATLX $6.90
- Analyst Decision
- MNOV Strong Buy
- ATLX Strong Buy
- Analyst Count
- MNOV 1
- ATLX 3
- Target Price
- MNOV $9.00
- ATLX $33.17
- AVG Volume (30 Days)
- MNOV 37.0K
- ATLX 85.6K
- Earning Date
- MNOV 02-13-2025
- ATLX 11-08-2024
- Dividend Yield
- MNOV N/A
- ATLX N/A
- EPS Growth
- MNOV N/A
- ATLX N/A
- EPS
- MNOV N/A
- ATLX N/A
- Revenue
- MNOV N/A
- ATLX $543,657.00
- Revenue This Year
- MNOV N/A
- ATLX N/A
- Revenue Next Year
- MNOV N/A
- ATLX $8,777.97
- P/E Ratio
- MNOV N/A
- ATLX N/A
- Revenue Growth
- MNOV N/A
- ATLX N/A
- 52 Week Low
- MNOV $1.12
- ATLX $6.12
- 52 Week High
- MNOV $2.55
- ATLX $26.24
- Technical
- Relative Strength Index (RSI)
- MNOV 35.00
- ATLX 48.46
- Support Level
- MNOV $1.90
- ATLX $6.80
- Resistance Level
- MNOV $2.20
- ATLX $7.25
- Average True Range (ATR)
- MNOV 0.08
- ATLX 0.45
- MACD
- MNOV -0.03
- ATLX 0.05
- Stochastic Oscillator
- MNOV 0.00
- ATLX 37.23
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.